← Leaderboards
Daniel J. Garry
University Of Texas Sw Med Ctr/Dallas
$21,785,493
Attributed
$29,548,287
Total exposure
28
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,548,287 · 28
By mechanism
R01$18,022,058 · 9
U01$7,752,733 · 1
P01$2,677,560 · 3
R43$301,098 · 1
R41$279,750 · 1
M01$256,528 · 11
Top collaborators
- Michael Kyba7 shared
- Jianyi Zhang7 shared
- Mary G Garry4 shared
- Jonathan M. Slack4 shared
- Dan S Kaufman3 shared
- Rita C. R. Perlingeiro3 shared
- Doris A Taylor3 shared
- Daniel Fred Carlson1 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Ralph P Mason$7,522,050
Others in their field
Top investigators on “Natural Regeneration”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Krzysztof Palczewski · University Of California-Irvine$30,602,053
- Edward E Morrisey · University Of Pennsylvania$30,099,314
- Elaine Fuchs · University Of Chicago$23,335,244
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,217,528
- Kenneth D Poss · Duke University$22,356,032
Research focus
Natural RegenerationStem CellsProgramsAdultMolecularMouse ModelBlood VesselsTechnologyCardiovascular DiseasesGenesLaboratoriesEngineeringCellsGene ExpressionMutantInnovationTranscription FactorCardiovascular SystemCardiacEmbryoEmerging TechnologiesPublishingTissuesGenetic Engineering
Grant awards (71)
Exogenic organs in gene edited pigs$746,895
R01 · FY2025 · AI · contact PI
Cardiovascular regeneration and pioneer factors$697,432
R01 · FY2025 · HL · contact PI
Project 2 - Shh and Etv2 Signaling Pathways and Cardiovascular Repair in Mouse and Pig$415,863
P01 · FY2025 · HL · contact PI
Bioengineering strategies for exogenic organ production$279,750
R41 · FY2025 · HL · contact PI
Cardiovascular regeneration and pioneer factors$683,484
R01 · FY2024 · HL · contact PI
Project 2 - Shh and Etv2 Signaling Pathways and Cardiovascular Repair in Mouse and Pig$421,408
P01 · FY2024 · HL · contact PI
Cardiovascular regeneration and pioneer factors$697,432
R01 · FY2023 · HL · contact PI
Project 2 - Shh and Etv2 Signaling Pathways and Cardiovascular Repair in Mouse and Pig$430,009
P01 · FY2023 · HL · contact PI
Bioengineering Strategies for Cardiovascular Disease$769,399
R01 · FY2022 · HL · contact PI
Mechanisms that Govern and Promote Cardiovascular Regeneration$747,299
R01 · FY2022 · HL · contact PI
Project 2 - Shh and Etv2 Signaling Pathways and Cardiovascular Repair in Mouse and Pig$397,988
P01 · FY2022 · HL · contact PI
Bioengineering Strategies for Cardiovascular Disease$769,399
R01 · FY2021 · HL · contact PI
Mechanisms that Govern and Promote Cardiovascular Regeneration$755,017
R01 · FY2021 · HL · contact PI
Bioengineering Strategies for Cardiovascular Disease$769,399
R01 · FY2020 · HL · contact PI
Mechanisms that Govern and Promote Cardiovascular Regeneration$762,582
R01 · FY2020 · HL · contact PI
Mechanisms that Govern and Promote Cardiovascular Regeneration$769,998
R01 · FY2019 · HL · contact PI
Bioengineering Strategies for Cardiovascular Disease$769,399
R01 · FY2019 · HL · contact PI
Regulatory Mechanisms of Endothelial Development and Regeneration$380,000
R01 · FY2017 · HL · contact PI
Regulatory Mechanisms of Endothelial Development and Regeneration$380,000
R01 · FY2016 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,104,105
U01 · FY2015 · HL · contact PI
Regulatory Mechanisms of Endothelial Development and Regeneration$374,300
R01 · FY2015 · HL · contact PI
Multiplex gene-editing to create multi-lineage ablated hosts for exogenic organ production$301,098
R43 · FY2015 · GM
Midwestern Progenitor Cell Consortium$1,098,208
U01 · FY2014 · HL · contact PI
Regulatory Mechanisms of Endothelial Development and Regeneration$380,000
R01 · FY2014 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,066,830
U01 · FY2013 · HL · contact PI
Transcriptional Regulation of Myogenic Stem Cells$299,937
R01 · FY2013 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2012 · HL · contact PI
Transcriptional Regulation of Myogenic Stem Cells$315,723
R01 · FY2012 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2011 · HL · contact PI
Transcriptional Regulation of Myogenic Stem Cells$315,723
R01 · FY2011 · AR · contact PI
MNF Regulation of Myogenic Stem Cells$299,372
R01 · FY2011 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,109,850
U01 · FY2010 · HL · contact PI
Transcriptional Regulation of Cardiac Morphogenesis$488,127
R01 · FY2010 · HL · contact PI
Transcriptional Regulation of Myogenic Stem Cells$328,878
R01 · FY2010 · AR · contact PI
MNF regulation of myogenic stem cells$311,847
R01 · FY2010 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,132,500
U01 · FY2009 · HL · contact PI
Transcriptional Regulation of Cardiac Morphogenesis$483,675
R01 · FY2009 · HL · contact PI
Transcriptional Regulation of Myogenic Stem Cells$332,200
R01 · FY2009 · AR · contact PI
MNF regulation of myogenic stem cells$314,997
R01 · FY2009 · AR · contact PI
MNF regulation of myogenic stem cells$314,997
R01 · FY2008 · AR · contact PI
Core A- Informatic Gene Array$402,451
P01 · FY2007 · HL · contact PI
MNF regulation of myogenic stem cells$321,425
R01 · FY2007 · AR · contact PI
NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025$20,666
M01 · FY2007 · RR · contact PI
Core A- Informatic Gene Array$309,426
P01 · FY2006 · HL · contact PI
NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025$47,128
M01 · FY2006 · RR · contact PI
WOMEN WHO INITIATE THERAPY OF HIV INFECTION DURING PREGNANCY PACTG 1022$20,198
M01 · FY2006 · RR · contact PI
A PROSPECTIVE OBSERVSTUDY OF VIROLOGIC /IMMUNOLOGIC CHANGES HIV WOMEN ACTG 5150$16,831
M01 · FY2006 · RR · contact PI
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUGS DURING PREGNANCY$7,853
M01 · FY2006 · RR · contact PI
ASSESSMENT OF PREVALENCE AND PERSISTANCE OF HUMAN PAPILLOMAVIRUS (HPV) DNA$2,245
M01 · FY2006 · RR · contact PI
Novel Cardioprotective Mechanisms Myoglobin null Mice$463,289
R01 · FY2005 · HL
MNF regulation of myogenic stem cells$351,000
R01 · FY2005 · AR
Core A- Informatic Gene Array$300,415
P01 · FY2005 · HL
WOMEN WHO INITIATE THERAPY OF HIV INFECTION DURING PREGNANCY PACTG 1022$37,382
M01 · FY2005 · RR
FASEB Conference: Skeletal muscle satellite/stem cells$35,000
R13 · FY2005 · AG
NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025$33,905
M01 · FY2005 · RR
VIROLOGIC /IMMUNOLOGIC CHANGES IN HIV WOMEN DURING POSTPARTUM ACTG 5150$14,780
M01 · FY2005 · RR
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL (HIV) DRUGS DURING PREGNANCY$1,740
M01 · FY2005 · RR
ASSESSMENT OF PREVALENCE AND PERSISTANCE OF HUMAN PAPILLOMAVIRUS (HPV) DNA$868
M01 · FY2005 · RR
Novel Cardioprotective Mechanisms Myoglobin null Mice$460,473
R01 · FY2004 · HL
MNF regulation of myogenic stem cells$351,000
R01 · FY2004 · AR
WOMEN WHO INITIATE THERAPY OF HIV INFECTION DURING PREGNANCY PACTG 1022$39,699
M01 · FY2004 · RR
NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025$7,058
M01 · FY2004 · RR
ASSESSMENT OF PREVALENCE AND PERSISTANCE OF HUMAN PAPILLOMAVIRUS (HPV) DNA$6,175
M01 · FY2004 · RR
Novel Cardioprotective Mechanisms Myoglobin null Mice$351,000
R01 · FY2003 · HL
MNF regulation of myogenic stem cells$351,000
R01 · FY2003 · AR
Novel Cardioprotective Mechanisms Myoglobin null Mice$76,360
R01 · FY2003 · HL
MNF regulation of myogenic stem cells$351,000
R01 · FY2002 · AR
Novel Cardioprotective Mechanisms Myoglobin null Mice$351,000
R01 · FY2002 · HL
MNF regulation of myogenic stem cells$337,000
R01 · FY2001 · AR
WINGED HELIX TRANSCRIPTION FACTORS AND MYOGENESIS$111,780
K08 · FY2001 · HL
WINGED HELIX TRANSCRIPTION FACTORS AND MYOGENESIS$111,780
K08 · FY2000 · HL